Source:http://linkedlifedata.com/resource/pubmed/id/10850617
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-9-6
|
pubmed:abstractText |
A simple, sensitive, selective and reliable reversed-phase high-performance liquid chromatographic (HPLC) method with UV detection is described for the determination of naltrexone in plasma samples. Naltrexone and the internal standard, naloxone, were isolated from plasma either with a liquid-liquid extraction method using ethyl acetate or with a solid-phase extraction method using Sep-Pack C18 cartridge before chromatography. The extracts were dried under a stream of nitrogen and the samples were reconstituted in the mobile phase, then 20 microL were injected on a Waters Symmetry C18 column (5 microm particle size, 4.6 x 150 mm). The mobile phase consisted of 0.06% triethylamine (pH 2.8)-acetonitrile (92:8, v/v) pumped at 1 mL/min. The peak-area ratio versus plasma concentration was linear over the range of 10-500 ng/mL and the detection limit was less than 8 ng/mL. Quantification was by ultra-violet detection at 204 nm. The present method was applied to the determination of the plasma concentration of naltrexone in dialyzed patients. Patients (n = 8) with severe generalized pruritus received 50 mg of naltrexone orally per day for 2 weeks. The variability in the therapeutic response in treated patients required plasma concentration investigations of this opioid antagonist.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0269-3879
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10850617-Chromatography, High Pressure Liquid,
pubmed-meshheading:10850617-Humans,
pubmed-meshheading:10850617-Kidney Failure, Chronic,
pubmed-meshheading:10850617-Naltrexone,
pubmed-meshheading:10850617-Narcotic Antagonists,
pubmed-meshheading:10850617-Pruritus,
pubmed-meshheading:10850617-Renal Dialysis,
pubmed-meshheading:10850617-Reproducibility of Results,
pubmed-meshheading:10850617-Sensitivity and Specificity
|
pubmed:year |
2000
|
pubmed:articleTitle |
High-performance liquid chromatographic determination of naltrexone in plasma of hemodialysis patients.
|
pubmed:affiliation |
Laboratoire de Pharmacologie, Pharmacocinétique et Pharmacie clinique, Faculté des Sciences Pharmaceutiques et Biologiques, Lille, France.
|
pubmed:publicationType |
Journal Article
|